A new survey by a healthcare technology solutions company has identified that manual follow-up procedures on late payments from insurance companies costs the organization 33% more per claim than previous estimates.
A new survey by a healthcare technology solutions company has identified that manual follow-up procedures on late payments from insurance companies costs the organization 33% more per claim than previous estimates. This despite the availability of automated procedures to follow-up on these billing processes.
Recondo Technology surveyed the claims follow-up procedures implemented by healthcare financial professionals from hospitals, physician groups, and consultant organizations. Traditionally done by back-office staff, previous estimates have found that claims follow-up costs between $2.75 and $3.75 per claim. However, nearly three-fourths of survey participants estimated this number at $4 per claim, which stood at nearly 33% more than what was widely assumed. A small number per claim, but a significant impact nonetheless. Recondo estimates that this tedious process could cost the industry over $3.1 billion more than was previously thought.
Jay Deady, CEO of Recondo, said, “Not only is it costing the industry more than is currently believed to find problems within the healthcare revenue cycle and remediate them, but the vast majority of healthcare organizations are relying on outdated means to automate claims follow-up, outsourcing it, or doing nothing at all.” He suggests using Web-sourced data to remove claims that are in queue to be paid off soon, which can free valuable staff time.
With over half the survey participants saying their organization used manual follow-up processes instead of using technologies that can automate the process, this is certainly a food for thought and an important value proposition for the healthcare financial world.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More